Vor Biopharma

Filed a patent for "methods for treating hematopoietic malignancy" on Thu, February 9, 2023

Filed a patent for "emr2 binding agents and methods of use thereof" on Mon, May 15, 2023

Filed a patent for "methods for treating hematopoietic malignancy" on Thu, June 8, 2023

Filed a patent for "methods for treating hematopoietic malignancy" on Thu, November 9, 2023

Filed a patent for "inhibitor oligonucleotides and methods of use thereof" on Wed, January 3, 2024

Filed a patent for "compositions and methods for bcma modification" on Fri, April 28, 2023

Filed a patent for "compositions and methods for artificial protospacer adjacent motif (pam) generation" on Wed, July 13, 2022

Filed a patent for "compositions and methods for allogeneic transplantation" on Thu, December 7, 2023

Filed a patent for "binding agents and methods of use thereof" on Fri, August 19, 2022

Filed a patent for "anti-cd45-ign antibody drug conjugates and uses thereof" on Tue, September 20, 2022

Filed a patent for "methods and compositions for gene modification and enrichment" on Thu, September 29, 2022

Filed a patent for "compositions and methods for mediating epitope engineering" on Wed, November 9, 2022

Filed a patent for "fc silenced antibody drug conjugates (adcs) and uses thereof" on Thu, March 7, 2024

Filed a patent for "anti-cd45-ign antibody drug conjugates and uses thereof" on Wed, February 8, 2023

Filed a patent for "anti-cd45-ign antibody drug conjugates and uses thereof" on Wed, February 15, 2023

Filed a patent for "compositions and methods for cd123 modification" on Mon, February 27, 2023

Filed a patent for "compositions and methods for cll1 modification" on Thu, April 4, 2024

Filed a patent for "chimeric antigen receptors for treatment of cancer" on Thu, November 23, 2023

Filed a patent for "compositions and methods for cd38 modification" on Thu, December 14, 2023

Filed a patent for "compositions and methods for cd5 modification" on Thu, February 8, 2024

Filed a patent for "compositions and methods for cd7 modification" on Thu, February 1, 2024

Filed a patent for "compositions and methods for cd6 modification" on Thu, November 16, 2023

Filed a patent for "chimeric antigen receptor expression systems" on Thu, November 16, 2023

Filed a patent for "compositions and methods for cd30 gene modification" on Thu, November 16, 2023

Filed a patent for "compositions and methods for treating hematopoietic malignancy" on Thu, January 4, 2024